PPT-Stroke: Highlights on Pathophysiology, Clinical Presentation, Acute Treatment and Prevention

Author : lois-ondreau | Published Date : 2018-12-07

Lama AlKhoury MD Clinical Assistant Professor Neurology UCI Medical Center Dec 8 th 2014 Stroke Epidemiology Incidence of stroke in USA is 795000 year in the United

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Stroke: Highlights on Pathophysiology, ..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Stroke: Highlights on Pathophysiology, Clinical Presentation, Acute Treatment and Prevention: Transcript


Lama AlKhoury MD Clinical Assistant Professor Neurology UCI Medical Center Dec 8 th 2014 Stroke Epidemiology Incidence of stroke in USA is 795000 year in the United States of America. Gout. and Hyperuricemia. By:. RS. Objectives. Definition. Epidemiology. Etiology. Pathophysiology:. overproduction of uric acid. Pathophysiology:. underexcretion . of uric acid. majority of patients (80% to 90%) with gout have a. Slide Kit. March 2013. Disclaimer. Please be aware pharmaceuticals presented here may have slightly different labels in different . countries.. For . more detailed information on the regulatory status, please contact the . Jeanne Carroll, RN, BA, CCRC. 2. Ivorine Yu, PhD. 1. Fen-Lei Chang, MD, PhD. 1,2,3. 1. Indiana University School of Medicine – Fort Wayne. 2. Parkview Neuroscience and Stanley Wissman Stroke Center. Presented by: Carrie Miller, MPH. . Ahmed . Alquthami, MD, MHSA. Introduction. Hypertension & . Stroke. Background. Pathophysiology. Significance. Descriptive Epidemiology. Causes. Prevention and control measures. Slide Kit. March 2013. Disclaimer. Please be aware pharmaceuticals presented here may have slightly different labels in different . countries.. For . more detailed information on the regulatory status, please contact the . Can We Open Up the Time Window. ?. David Wang, D.O.,FAHA, FAAN. Director, OSF/INI Stroke Network, CSC at OSF SFMC. Director, Stroke Fellowship. Clinical Professor of Neurology. UICOMP. S. tages of impaired cerebral circulation . . Ahmed . Alquthami, MD, MHSA. Introduction. Hypertension & . Stroke. Background. Pathophysiology. Significance. Descriptive Epidemiology. Causes. Prevention and control measures. Current research. Management. Justine Watkins. National Manager Clinical Services. Acknowledgements:. Guidelines Advisory Committee. Guidelines Content Development Working Groups: leaders and members. Stroke Foundation staff. Clinical Specialist Physiotherapist Hyper Acute Stroke UnitApril 2020Page 1Mater Misericordiae University HospitalDublinJob Title / Grade Clinical Specialist Physiotherapist Hyper Acute Stroke UnitDep Assist. Lect. . Shaymaa. . Hasan. Abbas. DESIRED TREATMENT OUTCOMES. The short-term goals for the treatment of hemorrhagic stroke include rapid . neurointensive. care treatment to maintain adequate oxygenation, breathing, and circulation. Management of increased intracranial pressure and blood pressure (BP) are important in the acute setting.. Disclaimer. Please be aware pharmaceuticals presented here may have slightly different labels in different . countries.. For . more detailed information on the regulatory status, please contact the . Assist.Lect. . . Shaymaa. . Hasan. Abbas. DESIRED TREATMENT OUTCOMES. The short-term goals of treatment for acute ischemic stroke include reducing secondary brain damage by re-establishing and maintaining adequate perfusion to marginally ischemic areas of the brain and to protect these areas from the effects of ischemia (i.e., . GPhC. National NHS Liaison. Since 2013 . pharmacists from . Interface Clinical Services have reviewed nearly . 300,000. AF patients across more than . 2,000. . sites. Interface have been supporting . Michela Rosso. CANCER AND STROKE. CANCER and VTE. LMWH . for at least 3 to 6 months . has . been the standard of care in treating cancer-associated . VTE [4]. .. Historically. , . LMWH . have been preferred for cancer-associated VTE .

Download Document

Here is the link to download the presentation.
"Stroke: Highlights on Pathophysiology, Clinical Presentation, Acute Treatment and Prevention"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents